SUBJECTS : Cancer Biology | Molecular Carcinogenesis | | Stem Cells | Developmental Biology | Oncolog
Cancer Treatment and Research Communications: 2023, vol: 36, issue:
- 1)- Flavia da Cunha Vasconcelos, Rodrigo Otavio de Castro Araujo, Paula Sabbo Bernardo, Thaís Hancio, Gabriela Nestal de Moraes, Ricardo de Sá Bigni, Marcus Valadão, Luciana Wernersbach Pinto, Raquel Ciuvalschi Maia. Primary colorectal diffuse large B-cell lymphoma: A report of eighteen cases in a tertiary care center. Cancer treatment and research communications. 2023, 36: 100722
Cited : 0Read More - 2)- Japneet Kaur, Abinaya Nadarajan, Deepak Janardhan, Nebu Abraham George, Shaji Thomas, Bipin T Varghese, Jagathnath Krishna. Predictive factors for nodal recurrence in differentiated thyroid cancers. Cancer treatment and research communications. 2023, 36: 100728Cited : 2Read More
- 3)- Vitor Caeiro, Bruno Esteves, José Fonseca-Moutinho. HPV testing for cervical cancer screening: Should reflex cytology be performed after a positive test for HPV 16 and 18? Cancer treatment and research communications. 2023, 36: 100729Cited : 0Read More
- 4)- Nikki M Carroll, Jennifer Eisenstein, Andrea N Burnett-Hartman, Robert T Greenlee, Stacey A Honda, Christine M Neslund-Dudas, Katharine A Rendle, Anil Vachani, Debra P Ritzwoller. Uptake of novel systemic therapy: Real world patterns among adults with advanced non-small cell lung cancer. Cancer treatment and research communications. 2023, 36: 100730Cited : 1Read More
- 5)- Niloufar Hoorshad, Saina Nassiri, Shaparak Najibi, Elham Feizabad, Narges Zamani. Synchronous endometrial and ovarian cancer and its recurrent risk factors: Case series. Cancer treatment and research communications. 2023, 36: 100731Cited : 2Read More
- 6)- Sholapuri Payani, Matcha Bhaskar, Gandham Sandeep Kumar, Jangampalli Adi Pradeepkiran. A study on antimicrobial and anticancer properties of Cissus quadrangulris using lung cancer cell line. Cancer treatment and research communications. 2023, 36: 100732Cited : 1Read More
- 7)- Marriott Morgan, Post Brittany, Chablani Lipika. Erratum to A comparison of cancer vaccine adjuvants in clinical trials [Cancer Treatment and Research Communications Volume 34, 2023, 100667]. Cancer treatment and research communications. 2023, 36: 100733Cited : 0Read More
- 8)- Tiwari Ramakant, Devnani Bharti, Thirunavukkarasu Balamurugan, Pareek Puneet, Daga Prateek, Kumar Amit. Erratum to Multi-modality management of chondrosarcoma of scapula: A case report and review of literature [Cancer Treatment and Research Communications Volume 35, 2023, 100710]. Cancer treatment and research communications. 2023, 36: 100737Cited : 0Read More
- 9)- L Bender, C Pflumio, P Trensz, L Pierard, M Kalish, C Fischbach, T Petit. Capecitabine efficacy after cycline-dependent-kinase 4/6 inhibitor plus endocrine therapy in metastatic hormone receptor-positive breast cancer. Cancer treatment and research communications. 2023, 36: 100738Cited : 0Read More
- 10)- Amirreza Heydari, Behnam Shakiba, Asaad Moradi, Saeed Esmaeil Soofian, Nasrollah Abian, Kazem Heidari, Robab Maghsoudi. Pharmaceutical industry funding and chemotherapy trials for prostate cancer: A systematic review. Cancer treatment and research communications. 2023, 36: 100739Cited : 0Read More
- 11)- Ryo Tanaka, Masaki Hiramitsu, Sakiko Shimizu, Shiori Kawashima, Akiko Sato, Yoichiro Iwase. Efficient drug delivery to lymph nodes by intradermal administration and enhancement of anti-tumor effects of immune checkpoint inhibitors. Cancer treatment and research communications. 2023, 36: 100740Cited : 1Read More
- 12)- Anshul Gupta, Ajay Gogia, Svs Deo, D N Sharma, Sandip Mathur, Hari Krishna Raju Sagiraju. Neoadjuvant chemotherapy with or without anthracyclines in combination with single HER2-targeted therapy in HER2-positive breast cancer. Cancer treatment and research communications. 2023, 36: 100741Cited : 1Read More
- 13)- Anne Shah, Jon Apple, Andrew J Belli, Anna Barcellos, Eric Hansen, Laura L Fernandes, Christina M Zettler, Ching-Kun Wang. Real-world study of disease-free survival & patient characteristics associated with disease-free survival in early-stage non-small cell lung cancer: A retrospective observational study. Cancer treatment and research communications. 2023, 36: 100742Cited : 3Read More
- 14)- Aakash Desai, Sagar Rakshit, Radhika Bansal, Yash Ashara, Ashley Potter, Rami Manochakian, Yanyan Lou, Yujie Zhao, Vinicius Ernani, Panos Savvides, Anna Schwecke, Nicole Moffett, Craig Hocum, Konstantinos Leventakos, Alex Adjei, Randolph Marks, Julian Molina, Aaron S Mansfield, Zong-Ming Chen, Anastasios Dimou. Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report. Cancer treatment and research communications. 2023, 36: 100743Cited : 4Read More
- 15)- Pradeep Natarajan, Munikumar Manne, Swetha Kumari Koduru, Teja Sree Bokkasam. 3-deazaadenosine: A promising novel p38γ antagonist with potential as a breast cancer therapeutic agent. Cancer treatment and research communications. 2023, 36: 100744Cited : 1Read More
- 16)- Ahmed K Awad, Rehmat Ullah Awan, Ayman K Awad, Ambreen Nabeel, Sophia Dar, Ayokunle T Abegunde. Patients with enteropathy-associated T-cell lymphoma in the United States from 2000 to 2018: SEER data-base analysis. Cancer treatment and research communications. 2023, 36: 100745Cited : 1Read More
- 17)- Ioannis A Voutsadakis. High tumor mutation burden (TMB) in microsatellite stable (MSS) colorectal cancers: Diverse molecular associations point to variable pathophysiology. Cancer treatment and research communications. 2023, 36: 100746Cited : 6Read More
- 18)- Stephane Thibodeau, Mahbuba Meem, Wilma Hopman, Simran Sandhu, Osbert Zalay, Andrea S Fung, Adi Kartolo, Geneviève C Digby, Shahad Al-Ghamdi, Andrew Robinson, Allison Ashworth, Timothy Owen, Aamer Mahmud, Kit Tam, Timothy Olding, Fabio Ynoe de Moraes. Survival outcomes and predicting intracranial metastasis in stage III non-small cell lung cancer treated with definitive chemoradiation: Real-world data from a tertiary cancer center. Cancer treatment and research communications. 2023, 36: 100747Cited : 0Read More
- 19)- Sabine Leerhoff, Arnold Raem, Ernst-Wolfgang Kolbe, Laura Schulz, Kirsten Borchers, Thomas Köhler, Günther Winde, Carmen Kirchner. Methylated Septin9 identified patients with colorectal carcinoma and showed higher sensitivity than conventional biomarkers in detecting tumor. Cancer treatment and research communications. 2023, 36: 100748Cited : 1Read More
- 20)- Rishabh Mittal, Sarath Krishnan M P, Rahul Saxena, Ananyan Sampath, Bela Goyal. Non-coding RNAs, cancer treatment and cardiotoxicity: A triad of new hope. Cancer treatment and research communications. 2023, 36: 100750Cited : 1Read More
- 21)- Alireza Hosseini-Abgir, Mohammad Mehdi Naghizadeh, Somayeh Igder, Behnoosh Miladpour. Insilco prediction of the role of the FriZZled5 gene in colorectal cancer. Cancer treatment and research communications. 2023, 36: 100751Cited : 0Read More
- 22)- Madeline MacDonald, Darin Poei, Alexis Leyba, Raymond Diep, Krithika Chennapan, Christopher Leon, Bing Xia, Jorge J Nieva, Robert Hsu. Real world prognostic utility of platelet lymphocyte ratio and nutritional status in first-line immunotherapy response in stage IV non-small cell lung cancer. Cancer treatment and research communications. 2023, 36: 100752Cited : 2Read More
